{
    "SPADE_UN_20731": {
        "Sequence Information": {
            "Peptide Name": "GRGEf-Mitoparan, GRGEf-Mastoparan [A5,8K; A10Aib]",
            "Sequence": "GRGEFINLKKLAKLXKKIL",
            "Sequence Length": 19,
            "Biological Activity": [
                "Anti-Gram+",
                "Anti-Gram-",
                "Antifungal",
                "Anti-Mammalian Cell"
            ],
            "Binding Target": "1. Lipid Bilayer",
            "Source": "",
            "Gene": "",
            "PDB ID": "",
            "UniProt Entry": [
                {
                    "uniprotId": "P01514",
                    "uniprotUrl": "http://www.uniprot.org/uniprot/P01514",
                    "description": "The amino acid sequence of the current peptide coincides with the amino acid sequence of the UniProt entry."
                }
            ],
            "Literature": [
                {
                    "Title": "The cationic tetradecapeptide mastoparan as a privileged structure for drug discovery: Enhanced antimicrobial properties of mitoparan analogues modified at position-14.",
                    "Pubmed ID": "29337270",
                    "Reference": "Peptides. 2018;101:95-105",
                    "Author": "Howl J, Howl L, Jones S",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/29337270"
                }
            ],
            "SPADE ID": "SPADE_UN_20731",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_N_08453",
                    "Similarity": 1.0,
                    "Sequence": "RGRGRGRGRG"
                },
                {
                    "SPADE_ID": "SPADE_UN_17266",
                    "Similarity": 1.0,
                    "Sequence": "HEHEHEHEHEHEHEHEEFGGGGGYGRGRGRGRGRGRG"
                },
                {
                    "SPADE_ID": "SPADE_UN_17267",
                    "Similarity": 1.0,
                    "Sequence": "HEHEHEHEHEHEHEHEHEHEEFGGGGGYGRGRGRGRGRGRG"
                }
            ],
            "Hemolytic Activity": "Human embryonic kidney HEK293 cells:50% Cytotoxicity=15.3-32 µg/ml,Human embryonic kidney HEK293 cells:97.4-99.7% Cytotoxicity=32 µg/ml",
            "Target Organism": "Staphylococcus aureus(MIC=8.0±0.0µg/ml),Escherichia coli(MIC=5.33±1.33µg/ml),Klebsiella pneumoniae(MIC=26.67±5.33µg/ml),Pseudomonas aeruginosa(MIC=32µg/ml),Acinetobacter baumannii(MIC=0.83±0.17µg/ml),Candida albicans(MIC=8.0±0.0µg/ml),Cryptococcus neoformans(MIC=0.67±0.17µg/ml)"
        }
    }
}